about
Melanized fungi in human diseaseCandida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsTreatment with echinocandins during continuous renal replacement therapyElucidation of substrate specificity in Aspergillus nidulans UDP-galactose-4-epimeraseNetwork Modeling Reveals Cross Talk of MAP Kinases during Adaptation to Caspofungin Stress in Aspergillus fumigatusIdentification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides GenusCandida albicans SUR7 contributes to secretion, biofilm formation, and macrophage killing.Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.Echinocandins: the newest class of antifungals.Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infectionAn anti-Aspergillus protein from Escherichia coli DH5α: putative inhibitor of siderophore biosynthesis in Aspergillus fumigatus.Preliminary X-ray crystallographic studies of UDP-glucose-4-epimerase from Aspergillus nidulansIn Vitro Antifungal Activity and Mode of Action of 2',4'-Dihydroxychalcone against Aspergillus fumigatus.Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literatureTreatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.Fungal infections: their diagnosis and treatment in transplant recipients.In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.In search of the holy grail of antifungal therapyCorrelation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.Use of terbinafine in rare and refractory mycoses.Antifungal agents--clinical pharmacokinetics and drug interactions.Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.Molecular and cellular mechanisms that lead to Candida biofilm formation.Invasive mold infections: recent advances in management approaches.Diagnosis and treatment of aspergillosis in children.Current perspectives on echinocandin class drugs.Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.Early state research on antifungal natural products.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: Cyclization is not essential for their antimicrobial activity.Echinocandins: The Expanding Antifungal Armamentarium.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.A Review of Antiviral and Antifungal Use and Safety during Pregnancy.
P2860
Q24633163-3C4948B2-5436-482A-A392-E8992ACA298DQ26863344-7D3619EA-A371-41C2-B9B8-65D2BC7D616FQ27012864-A165F00D-EA67-4D26-88FE-B020C454820BQ27680228-EED8B68C-DF3E-4E17-8D54-6EB117DBF812Q28547827-DB90EA32-36BF-493D-98E7-0575230761D9Q28550999-06AEBCFD-8B3A-4DE0-8812-E2A16645081FQ33569281-BE09EEAE-2E56-4939-A444-2F5604155ADDQ33811522-3EDE9322-9CBB-4708-8E99-D72748B5B7E3Q33956119-08D7E03C-C617-431D-BF70-B4773A21BF05Q34019188-0153766F-8EC6-4CC1-AB5A-DDF68DC2F4ADQ34101326-2F02D8B5-B61E-4562-A4FC-B9D5D60EFE14Q34309395-2380AC39-6342-4BED-AA7D-4D57EA5FD9A3Q34633796-8193F3DD-0A2D-4060-B37D-2EE6B6BF076EQ34966446-00BA4AA2-3851-4236-85B5-C3CD82FF1E70Q35150315-74BC4EE3-1E28-479D-8E21-92892AADAAC7Q35697196-907C111C-32A4-47AB-B1FA-2F7DB59E1246Q35959484-EBEAE086-900E-4964-8FBC-57BC87471B2CQ35959489-7CF00C3F-E76F-4AC1-AD92-0C42AFCC6EB7Q36135152-EE9AD3A6-E34F-4AEE-92DF-17E6C60E6660Q36206568-1BBE7CC7-54C9-438F-8BC1-088A95D14754Q36538739-80135EC2-4E24-4CCB-AD5A-D092D9955A74Q36644611-8D560EA9-A07D-4528-A292-70558FDB5325Q36672181-4DE45E89-148E-471F-9190-C78B46BC6197Q36845482-29672FB9-F885-40ED-BC43-8E67B23F717FQ37071133-12701ED4-C1A7-4B3E-9540-10C0E5CB5CFDQ37159568-94871240-95FF-44E4-AAC4-DBDA4DE0FC96Q37242216-137ECAA1-09CB-46E8-B6BB-F26C41689FE1Q37412802-AA8457B3-5BAA-43B0-974F-F15BA2E21521Q37428946-16B516FB-0912-4339-9531-05885A46F752Q37463228-9EAAB527-4C29-4995-A3DF-091B12356578Q37554055-5E9C0000-75A4-4B63-B5C0-3070EDE50DFBQ37613000-68E13599-5673-4BA5-805F-9885ABF4AAADQ37670259-416855A9-8397-45A4-B42D-348032788F72Q37759256-2F3F2FFE-A6D7-47E1-AF17-056A646C3F98Q38194442-B9D4279A-FBA0-45F8-A4B2-97ED3228D2C1Q38284468-88E5747E-F7B8-4576-AAC2-63DA93920914Q38404551-63C4B4B0-0B72-42E8-AED6-CE1C8CEEFE5EQ38633102-6B6B8CDE-88E8-4F48-A15C-F23B80237D50Q38681635-8594B119-4180-4DB6-94EE-3EA126EBA4E7Q38823841-F3CED23A-A3A3-466A-8B72-3A407015B13C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The echinocandins.
@ast
The echinocandins.
@en
type
label
The echinocandins.
@ast
The echinocandins.
@en
prefLabel
The echinocandins.
@ast
The echinocandins.
@en
P2860
P356
P1433
P1476
The echinocandins.
@en
P2093
Diane Cappelletty
Kasi Eiselstein-McKitrick
P2860
P304
P356
10.1592/PHCO.27.3.369
P407
P577
2007-03-01T00:00:00Z